Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 4/20 | 0.46 |
| ▸ | TET3 | O43151 | 1/20 | 0.46 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.45 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.45 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.45 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 8/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 8/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 5/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28385647 | 0.98 | TET2 (0.45) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL9768183 | 0.86 | TET2 (0.36) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL2821464 | 0.82 | TET2 (0.44) | TET2TET3TET1GRIK1GRIK2 | |
| (Chloromethyl)Benzene SCHEMBL8894823 | 0.80 | CHRNB2 (0.41) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL28715639 | 0.80 | TET2 (0.45) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL652699 | 0.80 | CHRNB2 (0.42) | GRIK1GRIK2GRM1GRM2CHRNB2 | |
| SCHEMBL1972700 | 0.78 | CHRNB2 (0.47) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL7608599 | 0.78 | TET2 (0.43) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL9821237 | 0.77 | TET2 (0.52) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL103866 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110746614-A | Preparation method and application of impact-resistant high-strength physical hydrogel | 西安交通大学 | 2020-02-04 | — | — | CN | claimed |
| US-20170320992-A1 | POLY(ALKYLENE CARBONATE)-BASED AMPHIPHILIC BLOCK COPOLYMERS AND METHODS OF USE THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2017-11-09 | — | — | US | claimed |
| WO-2016077614-A1 | POLY(ALKYLENE CARBONATE)-BASED AMPHIPHILIC BLOCK COPOLYMERS AND METHODS OF USE THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2016-05-19 | — | — | WO | claimed |
| EP-0218382-B1 | TREATMENT OF ARCHIVAL MATERIAL | The British Library (GB) | 1989-12-13 | — | — | EP | claimed |
| EP-0155797-B1 | TREATMENT OF ARCHIVAL MATERIAL | The British Library (GB) | 1989-07-26 | — | — | EP | claimed |
| US-4332779-A | Phosphoric acid filtration process | AMERICAN CYANAMID COMPANY (US) | 1982-06-01 | — | — | US | claimed |
| US-4295762-A | FREE RADICAL POLYMERIZATION CATALYST | NALCO CHEMICAL COMPANY (US) | 1981-10-20 | — | — | US | claimed |
| US-12227684-B2 | Method of manufacturing a core-shell structured quantum dot particle, core-shell structured quantum dot particle manufactured thereby, population of the core-shell structured quantum dot particles, and display device including the same | SHIN-A T&C (KR) | 2025-02-18 | — | — | US | disclosed |
| US-20250041168-A1 | Solid Personal Care Product and Method to Obtain Such Product | UNIVERSITAT INTERNACIONAL DE CATALUNYA, FUNDACIÓ PRIVADA (ES) | 2025-02-06 | — | — | US | disclosed |
| EP-4452176-A1 | SOLID PERSONAL CARE PRODUCT AND METHOD TO OBTAIN SUCH PRODUCT | Universitat Internacional De Catalunya, Fundació Privada (ES) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023118255-A1 | SOLID PERSONAL CARE PRODUCT AND METHOD TO OBTAIN SUCH PRODUCT | UNIVERSITAT INTERNACIONAL DE CATALUNYA, FUNDACIÓ PRIVADA (ES) | 2023-06-29 | — | — | WO | disclosed |
| EP-4201392-A1 | SOLID PERSONAL CARE PRODUCT AND METHOD TO OBTAIN SUCH PRODUCT | Universitat Internacional De Catalunya, Fundació Privada (ES) | 2023-06-28 | — | — | EP | disclosed |
| US-20220228058-A1 | METHOD OF MANUFACTURING A CORE-SHELL STRUCTURED QUANTUM DOT PARTICLE, CORE-SHELL STRUCTURED QUANTUM DOT PARTICLE MANUFACTURED THEREBY, POPULATION OF THE CORE-SHELL STRUCTURED QUANTUM DOT PARTICLES, AND DISPLAY DEVICE INCLUDING THE SAME | UNIAM (KR) | 2022-07-21 | — | — | US | disclosed |
| US-4561952-A | Water reducible quaternary ammonium salt containing polymers | THE SHERWIN-WILLIAMS COMPANY (US) | 1985-12-31 | — | — | US | disclosed |
| EP-0164669-A2 | Process for coating pharmaceutical forms | RÖHM GMBH (DE) | 1985-12-18 | — | — | EP | disclosed |
| EP-0130576-A2 | Colour concentrates containing acrylic resins as binders | RÖHM GMBH (DE) | 1985-01-09 | — | — | EP | disclosed |
| US-4444955-A | Water reducible quaternary ammonium salt containing polymers | THE SHERWIN-WILLIAMS COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-4444954-A | WITH ACTIVE HYDROGEN-CONTAINING MONOMER AND A BLOCKED POLYISOCYANATE | THE SHERWIN-WILLIAMS COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-4420541-A | QUATERNARY AMMONIUM SALT OF TERT-AMINOALKYL ACRYLATE OR ACRYLAMIDE AND AN ORGANIC HALIDE | THE SHERWIN-WILLIAMS COMPANY (US) | 1983-12-13 | — | — | US | disclosed |
| US-4322331-A | Radiation polymerizable compounds and conductive coatings from same | THE SHERWIN-WILLIAMS COMPANY (US) | 1982-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170320992-A1 | POLY(ALKYLENE CARBONATE)-BASED AMPHIPHILIC BLOCK COPOLYMERS AND METHODS OF USE THEREOF | PARG, PICALM, PHOSPHO1 | TET2 2004/4885TET3 399/4885TET1 1135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.